Literature DB >> 25328143

Osteopontin is associated with inflammation and mortality in a mouse model of polymicrobial sepsis.

S Fortis1, R G Khadaroo, J J Haitsma, H Zhang.   

Abstract

BACKGROUND: Osteopontin (OPN) is a multifunctional glycoprotein with pro-inflammatory properties. In severe sepsis, levels of plasma OPN are significantly higher in non-survivors than in survivors. We hypothesized that OPN results in greater inflammation and worse outcome through modulation of endogenous glucocorticoid production in sepsis. METHODS AND
RESULTS: Sepsis was induced by cecal ligation and puncture (CLP) in wild type (WT) and OPN gene knockout (OPN(-/-) ) mice. In response to sepsis, the OPN(-/-) mice had lower levels of plasma cytokines and chemokines than the WT mice. The levels of corticosterone in plasma were similar between WT and OPN(-/-) sham animals but they increased 24 h after CLP induction in the WT mice, but not in the OPN(-/-) mice. The mortality rate was lower in the OPN(-/-) mice than in the WT mice.
CONCLUSION: OPN is associated with greater inflammatory response and increased mortality, despite the higher corticosterone levels in plasma. Corticosterone production is not impaired in the absence of OPN.
© 2014 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25328143      PMCID: PMC4936904          DOI: 10.1111/aas.12422

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  23 in total

1.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity.

Authors:  S Ashkar; G F Weber; V Panoutsakopoulou; M E Sanchirico; M Jansson; S Zawaideh; S R Rittling; D T Denhardt; M J Glimcher; H Cantor
Journal:  Science       Date:  2000-02-04       Impact factor: 47.728

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

3.  Osteopontin impairs host defense during pneumococcal pneumonia.

Authors:  Gerritje J W van der Windt; Arie J Hoogendijk; Marcel Schouten; Tijmen J Hommes; Alex F de Vos; Sandrine Florquin; Tom van der Poll
Journal:  J Infect Dis       Date:  2011-06-15       Impact factor: 5.226

4.  Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.

Authors:  H J Harris; Y Kotelevtsev; J J Mullins; J R Seckl; M C Holmes
Journal:  Endocrinology       Date:  2001-01       Impact factor: 4.736

Review 5.  The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes.

Authors:  Z Krozowski; K X Li; K Koyama; R E Smith; V R Obeyesekere; A Stein-Oakley; H Sasano; C Coulter; T Cole; K E Sheppard
Journal:  J Steroid Biochem Mol Biol       Date:  1999 Apr-Jun       Impact factor: 4.292

6.  Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.

Authors:  Shirley H J Mei; Jack J Haitsma; Claudia C Dos Santos; Yupu Deng; Patrick F H Lai; Arthur S Slutsky; W Conrad Liles; Duncan J Stewart
Journal:  Am J Respir Crit Care Med       Date:  2010-06-17       Impact factor: 21.405

7.  Osteopontin impairs host defense during established gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis).

Authors:  Gerritje J W van der Windt; W Joost Wiersinga; Catharina W Wieland; Ivo C S I Tjia; Nicholas P Day; Sharon J Peacock; Sandrine Florquin; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31

8.  Osteopontin regulates hindlimb-unloading-induced lymphoid organ atrophy and weight loss by modulating corticosteroid production.

Authors:  Kathryn X Wang; Yufang Shi; David T Denhardt
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-04       Impact factor: 11.205

9.  Osteopontin-dependent regulation of Th1 and Th17 cytokine responses in Trypanosoma cruzi-infected C57BL/6 mice.

Authors:  Miguel H Santamaría; Ricardo S Corral
Journal:  Cytokine       Date:  2012-11-28       Impact factor: 3.861

10.  Serum levels of osteopontin are increased in SIRS and sepsis.

Authors:  Rosanna Vaschetto; Stefania Nicola; Carlo Olivieri; Elena Boggio; Fabio Piccolella; Riccardo Mesturini; Federica Damnotti; Davide Colombo; Paolo Navalesi; Francesco Della Corte; Umberto Dianzani; Annalisa Chiocchetti
Journal:  Intensive Care Med       Date:  2008-09-20       Impact factor: 17.440

View more
  7 in total

1.  Schisandrin B Attenuates Inflammation in LPS-Induced Sepsis Through miR-17-5p Downregulating TLR4.

Authors:  Zhi-Rong Ji; Wei-Liang Xue; Ling Zhang
Journal:  Inflammation       Date:  2019-04       Impact factor: 4.092

2.  Neutralization of osteopontin attenuates neutrophil migration in sepsis-induced acute lung injury.

Authors:  Yohei Hirano; Monowar Aziz; Weng-Lang Yang; Zhimin Wang; Mian Zhou; Mahendar Ochani; Adam Khader; Ping Wang
Journal:  Crit Care       Date:  2015-02-26       Impact factor: 9.097

3.  Persistently elevated osteopontin serum levels predict mortality in critically ill patients.

Authors:  Christoph Roderburg; Fabian Benz; David Vargas Cardenas; Matthias Lutz; Hans-Joerg Hippe; Tom Luedde; Christian Trautwein; Norbert Frey; Alexander Koch; Frank Tacke; Mark Luedde
Journal:  Crit Care       Date:  2015-06-26       Impact factor: 9.097

4.  Osteopontin Expression in Cardiomyocytes Is Increased in Pediatric Patients With Sepsis or Pneumonia.

Authors:  Camila Iansen Irion; Kiera Parrish; Krista John-Williams; Sakir H Gultekin; Lina A Shehadeh
Journal:  Front Physiol       Date:  2018-12-10       Impact factor: 4.566

5.  The Role of Osteopontin as a Diagnostic and Prognostic Biomarker in Sepsis and Septic Shock.

Authors:  Luigi Mario Castello; Marco Baldrighi; Luca Molinari; Livia Salmi; Vincenzo Cantaluppi; Rosanna Vaschetto; Greta Zunino; Marco Quaglia; Mattia Bellan; Francesco Gavelli; Paolo Navalesi; Gian Carlo Avanzi; Annalisa Chiocchetti
Journal:  Cells       Date:  2019-02-18       Impact factor: 6.600

6.  A long journey for acute kidney injury biomarkers.

Authors:  Dong-Jin Oh
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

7.  ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.

Authors:  Gustavo Ferreira Alves; Ian Stoppa; Eleonora Aimaretti; Chiara Monge; Raffaella Mastrocola; Elisa Porchietto; Giacomo Einaudi; Debora Collotta; Ilaria Bertocchi; Elena Boggio; Casimiro Luca Gigliotti; Nausicaa Clemente; Manuela Aragno; Daniel Fernandes; Carlo Cifani; Christoph Thiemermann; Chiara Dianzani; Umberto Dianzani; Massimo Collino
Journal:  Front Immunol       Date:  2022-09-02       Impact factor: 8.786

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.